PMID- 22142194 OWN - NLM STAT- MEDLINE DCOM- 20120409 LR - 20231019 IS - 1470-8728 (Electronic) IS - 0264-6021 (Print) IS - 0264-6021 (Linking) VI - 442 IP - 2 DP - 2012 Mar 1 TI - Secreted CXCL12 (SDF-1) forms dimers under physiological conditions. PG - 433-42 LID - 10.1042/BJ20111341 [doi] AB - Chemokine CXCL12 (CXC chemokine ligand 12) signalling through CXCR (CXC chemokine receptor) 4 and CXCR7 has essential functions in development and underlies diseases including cancer, atherosclerosis and autoimmunity. Chemokines may form homodimers that regulate receptor binding and signalling, but previous studies with synthetic CXCL12 have produced conflicting evidence for homodimerization. We used bioluminescence imaging with GL (Gaussia luciferase) fusions to investigate dimerization of CXCL12 secreted from mammalian cells. Using column chromatography and GL complementation, we established that CXCL12 was secreted from mammalian cells as both monomers and dimers. Secreted CXCL12 also formed homodimers in the extracellular space. Monomeric CXCL12 preferentially activated CXCR4 signalling through Galphai and Akt, whereas dimeric CXCL12 more effectively promoted recruitment of beta-arrestin 2 to CXCR4 and chemotaxis of CXCR4-expressing breast cancer cells. We also showed that CXCR7 preferentially sequestered monomeric CXCL12 from the extracellular space and had minimal effects on dimeric CXCL12 in cell-based assays and an orthotopic tumour xenograft model of human breast cancer. These studies establish that CXCL12 secreted from mammalian cells forms homodimers under physiological conditions. Since monomeric and dimeric CXCL12 have distinct effects on cell signalling and function, our results have important implications for ongoing efforts to target CXCL12 pathways for therapy. FAU - Ray, Paramita AU - Ray P AD - Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, MI 48109, U.S.A. FAU - Lewin, Sarah A AU - Lewin SA FAU - Mihalko, Laura Anne AU - Mihalko LA FAU - Lesher-Perez, Sasha-Cai AU - Lesher-Perez SC FAU - Takayama, Shuichi AU - Takayama S FAU - Luker, Kathryn E AU - Luker KE FAU - Luker, Gary D AU - Luker GD LA - eng GR - T32 GM008353/GM/NIGMS NIH HHS/United States GR - R01CA136553/CA/NCI NIH HHS/United States GR - R01CA136829/CA/NCI NIH HHS/United States GR - R01 CA136829/CA/NCI NIH HHS/United States GR - T32 GM145304/GM/NIGMS NIH HHS/United States GR - R01 CA136553/CA/NCI NIH HHS/United States GR - P50CA093990/CA/NCI NIH HHS/United States GR - P50 CA093990/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (ACKR3 protein, human) RN - 0 (CXCL12 protein, human) RN - 0 (CXCR4 protein, human) RN - 0 (Chemokine CXCL12) RN - 0 (Receptors, CXCR) RN - 0 (Receptors, CXCR4) RN - 0 (Recombinant Fusion Proteins) RN - EC 1.13.12.7 (Luciferases, Firefly) SB - IM MH - Animals MH - Breast Neoplasms/metabolism MH - Cell Line, Tumor MH - Chemokine CXCL12/*chemistry/genetics/*physiology MH - Dimerization MH - Extracellular Space/metabolism MH - Female MH - HEK293 Cells MH - Humans MH - Luciferases, Firefly/genetics/metabolism MH - Mice MH - Mice, Inbred NOD MH - Mice, SCID MH - Neoplasm Transplantation MH - Protein Structure, Quaternary MH - Receptors, CXCR/metabolism MH - Receptors, CXCR4/metabolism MH - Recombinant Fusion Proteins/chemistry/genetics/metabolism MH - Signal Transduction MH - Transplantation, Heterologous PMC - PMC4419379 MID - NIHMS684613 EDAT- 2011/12/07 06:00 MHDA- 2012/04/10 06:00 PMCR- 2015/05/05 CRDT- 2011/12/07 06:00 PHST- 2011/12/07 06:00 [entrez] PHST- 2011/12/07 06:00 [pubmed] PHST- 2012/04/10 06:00 [medline] PHST- 2015/05/05 00:00 [pmc-release] AID - BJ20111341 [pii] AID - 10.1042/BJ20111341 [doi] PST - ppublish SO - Biochem J. 2012 Mar 1;442(2):433-42. doi: 10.1042/BJ20111341.